Atractylenolide-I Suppresses Tumorigenesis of Breast Cancer by Inhibiting Toll-Like Receptor 4-Mediated Nuclear Factor-κB Signaling Pathway

Atractylenolide I Induces Apoptosis and Suppresses Glycolysis by Blocking the JAK2/STAT3 Signaling Pathway in Colorectal Cancer Cells

(2020) Yanxi Li et al.   Frontiers in Pharmacology

Antioxidant, Antimicrobial and Anti‐Inflammatory Activities of Essential Oil Derived from the Wild Rhizome of Atractylodes macrocephala

(2020) Yong‐Xiang Wu et al.   CHEMISTRY & BIODIVERSITY

Effects of Betaine on LPS-Stimulated Activation of Microglial M1/M2 Phenotypes by Suppressing TLR4/NF-κB Pathways in N9 Cells

(2019) Hui Shi et al.   MOLECULES

TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition

(2019) Zahra Zandi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The antitumor effect of hinesol, extract from Atractylodes lancea ( Thunb. ) DC. by proliferation, inhibition, and apoptosis induction via MEK/ERK and NF‐κB pathway in non–small cell lung cancer cell lines A549 and NCI‐H1299

(2019) Weiqiang Guo et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Inhibition of TLR4/TRIF/IRF3 Signaling Pathway by Curcumin in Breast Cancer Cells

(2019) Gamze Güney Eskiler et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

The Role of TLRs in Anti-cancer Immunity and Tumor Rejection

(2019) Zuzanna Urban-Wojciuk et al.   Frontiers in Immunology

The JAK2/STAT3 pathway is involved in the anti-melanoma effects of atractylenolide I

(2018) Xiu-Qiong Fu et al.   EXPERIMENTAL DERMATOLOGY

The Cancer Prevention, Anti-Inflammatory and Anti-Oxidation of Bioactive Phytochemicals Targeting the TLR4 Signaling Pathway

(2018) Chung-Yi Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Toll-like receptor 4 and breast cancer: an updated systematic review

(2018) Morteza Khademalhosseini et al.   Breast Cancer

Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease

(2017) et al.   Nutrients

Chemopreventive effects of atractylenolide II on mammary tumorigenesis via activating Nrf2-ARE pathway

(2017) Ting Wang et al.   Oncotarget

Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma

(2016) Federico Rojo et al.   BRITISH JOURNAL OF CANCER

Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro

(2016) Hong Liu et al.   Journal of Translational Medicine

Atractylenolide I protects mice from lipopolysaccharide-induced acute lung injury

(2015) Jun-liang Zhang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling

(2014) Agnieszka Płóciennikowska et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy

(2014) Wei Wang et al.   CURRENT MEDICINAL CHEMISTRY

A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib

(2014) A Ray et al.   LEUKEMIA

Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs

(2013) Geniey Yang et al.   PHARMACOLOGY & THERAPEUTICS

Links between Toll-like receptor 4 and breast cancer

(2013) Abubakr Ahmed et al.   OncoImmunology

Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion

(2012) Huan Yang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration

(2011) Sheng-Jun Liao et al.   BREAST CANCER RESEARCH AND TREATMENT

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

(2010) Taro Kawai et al.   NATURE IMMUNOLOGY

Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden

(2010) L Connelly et al.   ONCOGENE

A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients

(2007) Yi Liu et al.   Evidence-based Complementary and Alternative Medicine